GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:14749390

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Stefanovic, B, Stefanovic, L, Schnabl, B, Bataller, R and Brenner, DA (2004) TRAM2 protein interacts with endoplasmic reticulum Ca2+ pump Serca2b and is necessary for collagen type I synthesis. Mol. Cell. Biol. 24:1758-68

Abstract

Cotranslational insertion of type I collagen chains into the lumen of the endoplasmic reticulum (ER) and their subsequent folding into a heterotrimeric helix is a complex process which requires coordinated action of the translation machinery, components of translocons, molecular chaperones, and modifying enzymes. Here we describe a role for the protein TRAM2 in collagen type I expression in hepatic stellate cells (HSCs) and fibroblasts. Activated HSCs are collagen-producing cells in the fibrotic liver. Quiescent HSCs produce trace amounts of type I collagen, while upon activation collagen synthesis increases 50- to 70-fold. Likewise, expression of TRAM2 dramatically increases in activated HSCs. TRAM2 shares 53% amino acid identity with the protein TRAM, which is a component of the translocon. However, TRAM2 has a C terminus with only a 15% identity. The C-terminal part of TRAM2 interacts with the Ca(2+) pump of the ER, SERCA2b, as demonstrated in a Saccharomyces cerevisiae two-hybrid screen and by immunoprecipitations in human cells. TRAM2 also coprecipitates with anticollagen antibody, suggesting that these two proteins interact. Deletion of the C-terminal part of TRAM2 inhibits type I collagen synthesis during activation of HSCs. The pharmacological inhibitor of SERCA2b, thapsigargin, has a similar effect. Depletion of ER Ca(2+) with thapsigargin results in inhibition of triple helical collagen folding and increased intracellular degradation. We propose that TRAM2, as a part of the translocon, is required for the biosynthesis of type I collagen by coupling the activity of SERCA2b with the activity of the translocon. This coupling may increase the local Ca(2+) concentration at the site of collagen synthesis, and a high Ca(2+) concentration may be necessary for the function of molecular chaperones involved in collagen folding.

Links

PubMed PMC344171

Keywords

Amino Acid Sequence; Animals; Calcium/metabolism; Calcium-Transporting ATPases/antagonists & inhibitors; Calcium-Transporting ATPases/metabolism; Cells, Cultured; Cloning, Molecular; Collagen Type I/biosynthesis; Collagen Type I/chemistry; Collagen Type I/genetics; Collagen Type I/metabolism; Disulfides/metabolism; Endoplasmic Reticulum/drug effects; Endoplasmic Reticulum/enzymology; Endoplasmic Reticulum/metabolism; Fibroblasts/drug effects; Fibroblasts/metabolism; Hepatocytes/metabolism; Humans; Imidazoles/pharmacology; Membrane Glycoproteins/chemistry; Membrane Glycoproteins/genetics; Membrane Glycoproteins/metabolism; Mice; Molecular Sequence Data; Protein Binding; RNA, Messenger/genetics; RNA, Messenger/metabolism; Rats; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sequence Deletion; Thapsigargin/pharmacology

public



Cancel